97 related articles for article (PubMed ID: 20815986)
41. [Expression and clinical significance of apoptosis associated genes Livin and Smac/DIABLO in human gastric carcinomas].
Zhao Y; Deng X; Wang Q
Ai Zheng; 2009 Jun; 28(6):593-601. PubMed ID: 19635196
[TBL] [Abstract][Full Text] [Related]
42. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
[TBL] [Abstract][Full Text] [Related]
43. [Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer].
Yang Q; Zhu RQ; Fang Z; Xia D; Diao LM; Liu MQ
Ai Zheng; 2005 Mar; 24(3):321-6. PubMed ID: 15757534
[TBL] [Abstract][Full Text] [Related]
44. [The serum concentration of metalloproteinase 9 and 2 in non-small cell lung cancer patients].
Kopczyńska E; Dancewicz M; Kowalewski J; Kardymowicz H; Tyrakowski T
Pol Merkur Lekarski; 2007 Jun; 22(132):539-41. PubMed ID: 17874625
[TBL] [Abstract][Full Text] [Related]
45. [Clinical significance of cytokeratin 19 mRNA expression in peripheral leucocytes in patients with non-small cell lung cancer].
Wang ZH; Kong L; Liu J
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):53. PubMed ID: 17575695
[No Abstract] [Full Text] [Related]
46. High serum concentrations of Sialyl Lewisx predict multilevel N2 disease in non-small-cell lung cancer.
Mizuguchi S; Inoue K; Iwata T; Nishida T; Izumi N; Tsukioka T; Nishiyama N; Uenishi T; Suehiro S
Ann Surg Oncol; 2006 Jul; 13(7):1010-8. PubMed ID: 16788764
[TBL] [Abstract][Full Text] [Related]
47. Expression of livin in renal cell carcinoma and detection of anti-livin autoantibody in patients.
Kitamura H; Honma I; Torigoe T; Hariu H; Asanuma H; Hirohashi Y; Sato E; Sato N; Tsukamoto T
Urology; 2007 Jul; 70(1):38-42. PubMed ID: 17656204
[TBL] [Abstract][Full Text] [Related]
48. [Use of determination of the serum carcinoembryonic antigen in oncopulmonology].
Lazarev SM; Reshetov AV; Nikolaev GV; Volgin GN; Nokhrin AV; Kokorin DM
Vestn Khir Im I I Grek; 2009; 168(3):21-5. PubMed ID: 19663274
[TBL] [Abstract][Full Text] [Related]
49. [Role of biological tumor markers CEA, Cyfra-21, NSE, TU M2-PK in diagnosis and treatment of lung cancer].
Lazarev SM; Massard Zh; Reshetov AV; Nikolaev GV; Volgin GN; Osipov EV; Lomteva EIu; Nokhrin AV; Kakysheva OE
Vestn Khir Im I I Grek; 2010; 169(1):39-43. PubMed ID: 20387605
[TBL] [Abstract][Full Text] [Related]
50. Cytokeratin 8 and 18 fragments measured in serum and their relation to survival in patients with non-small cell lung cancer.
Bergqvist M; Brattström D; Hesselius P; Wiklund B; Silen A; Wagenius G; Brodin O
Anticancer Res; 1999; 19(3A):1833-6. PubMed ID: 10470123
[TBL] [Abstract][Full Text] [Related]
51. A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma.
Planque C; Li L; Zheng Y; Soosaipillai A; Reckamp K; Chia D; Diamandis EP; Goodglick L
Clin Cancer Res; 2008 Mar; 14(5):1355-62. PubMed ID: 18316555
[TBL] [Abstract][Full Text] [Related]
52. Serum levels of interleukin-6 as a prognostic factor in advanced non-small cell lung cancer.
De Vita F; Orditura M; Auriemma A; Infusino S; Roscigno A; Catalano G
Oncol Rep; 1998; 5(3):649-52. PubMed ID: 9538169
[TBL] [Abstract][Full Text] [Related]
53. [Analysis of RASSF1A promoter hypermethylation in serum DNA of non-small cell lung cancer].
Yu ZH; Wang YC; Chen LB; Song Y; Liu C; Xia XY; Lin Q; Ma CY
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):284-7. PubMed ID: 18788633
[TBL] [Abstract][Full Text] [Related]
54. [Prognostic factors in unresectable lung cancer].
Urata A
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2035-42. PubMed ID: 2840034
[TBL] [Abstract][Full Text] [Related]
55. [Immunologic tests: Anti-Survivin and anti-Livin antibodies].
Yagihashi A
Nihon Rinsho; 2005 Jul; 63 Suppl 7():637-9. PubMed ID: 16111355
[No Abstract] [Full Text] [Related]
56. The clinical effect of the inhibitor of apopotosis protein livin in melanoma.
Lazar I; Perlman R; Lotem M; Peretz T; Ben-Yehuda D; Kadouri L
Oncology; 2012; 82(4):197-204. PubMed ID: 22441029
[TBL] [Abstract][Full Text] [Related]
57. High expression of Livin serves as a predictive indicator for parotid gland tumors.
Xu H; Cheng Z; Liu DW; Chen L
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5223-5228. PubMed ID: 31298372
[TBL] [Abstract][Full Text] [Related]
58. Livin and caspase-3 expression are negatively correlated in cervical squamous cell cancer.
Xu M; Xia LP; Fan LJ; Xue JL; Shao WW; Xu D
Eur J Gynaecol Oncol; 2013; 34(2):152-5. PubMed ID: 23781587
[TBL] [Abstract][Full Text] [Related]
59. Effect of topotecan on retinocytoma cell apoptosis and expression of Livin and PTEN.
Zhang M; Shan BE; Yuan NF; Liu W
Chin Med J (Engl); 2013 Jan; 126(2):340-4. PubMed ID: 23324287
[TBL] [Abstract][Full Text] [Related]
60. Expression of livin, survivin and caspase-3 in prostatic cancer and their clinical significance.
Gu J; Ren L; Wang X; Qu C; Zhang Y
Int J Clin Exp Pathol; 2015; 8(11):14034-9. PubMed ID: 26823716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
